Association of Serum Inflammatory Factors and Hematologic Parameters With Lower Limb Deep Vein Thrombosis in Neurocritical Patients: A Retrospective Cohort Study
Abstract
Objective: The aim of this study was to investigate the mechanisms of postoperative deep vein thrombosis (DVT) of the lower extremities in neurocritical care patients, focusing on the interaction of inflammatory factors [D-dimer (DD), prothrombin time (PT), blood cell parameters (lymphocytes, platelets, plateletcrit) and coagulation function.
Methods: A retrospective cohort study design was used to include 261 neurocritical care patients who underwent surgery between August 2019 and August 2021. They were categorized into DVT group (n=121) and non-DVT group (n=140) based on postoperative lower limb Doppler ultrasound findings. Preoperative coagulation indices (TT, DD), inflammatory markers [C reactive protein (CRP), procalcitonin (PCT), fibrinogen (FIB)], and blood cell parameters (hemoglobin, neutrophils, lymphocytes, platelet counts, and plateletcrit) were collected from the patients.
Results: DD levels were significantly higher and TT shorter in the DVT group than in the non-DVT group (P<0.05); DD was positively correlated with PT-INR (P<0.001). In addition, lymphocyte and plateletcrit were significantly lower in the DVT group (P<0.05). Multifactorial analysis showed that age (OR=1.027), days of hemostatic medication (OR=1.203), postoperative infections (OR=2.728), elevated DD (OR=1.056), and shortened TT (OR=0.840) were independent risk factors (P<0.05).
Conclusion: The development of DVT in neurocritical patients is the result of a combination of hypercoagulation, inflammatory response, and immunosuppression.
Copyright (c) 2025 Yunqiu Zhu, Chun Wang, Jia Wang, Tian Shi, Weijie Tang, Huaping Zhou, Wanfei Guo, Hongbin Mei, Jinxiang Bo

This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
